LRTX — Lirum Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Lirum Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0 | 0.174 | 4.01 |
| Total Other Current Assets | |||
| Total Current Assets | 0 | 0.41 | 4.57 |
| Total Assets | 0 | 0.41 | 4.57 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Current Liabilities | 0.002 | 1.83 | 2.18 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.002 | 2.33 | 2.18 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -0.002 | -1.92 | 2.39 |
| Total Liabilities & Shareholders' Equity | 0 | 0.41 | 4.57 |
| Total Common Shares Outstanding |